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It  has  been  reported in previous  communications (1)  that  intra- 
venous injections of mixtures of serum precipitinogens with precipitat- 
ing antisera produced severe hemorrhagic necrosis in rabbit skin sites 
prepared with bacterial filtrates.  The reacting potency of the  mix- 
tures did not depend on the degree of turbidity formed.  Also, clear 
supernatant fluids obtained by centrifugalization of partially precipi- 
tated sara elicited severe reactions.  It was concluded from these and 
other observations that the reacting potency of the mixtures was not 
due to the mechanical effect of colloidal particles in the blood stream 
but to some toxic factors liberated or formed in the sara through the 
colloidal disturbance of the antigen-antibody interaction.  The pur- 
pose  of the work embodied in  the present  paper  was  to  determine 
whether the reaction between the antigen and antibody induced in 
vivo  would  bring  about  formation of  reacting  factors  in  the  blood 
stream. 
Formation  of Reacting  Factors  in  Actively  Sensitized  Rabbits 
In this part of the work rabbits were sensitized  by single  or repeated intravenous 
injections of animal proteins.  After various intervals of time they were prepared 
by single intradermal injections of 0.25 cc. of undiluted bacterial "agar washings" 
filtrate.  The skin-preparatory potency of the filtrates employed  was ascertained 
in the usual manner prior to the experiments (2).  24 hours after the skin prepa- 
ration the rabbits received single intravenous injections of the animal protein to 
which they were previously sensitized (i.e.,  test injections).  For repeated skin 
preparations in retests with the same or various proteins, a different bacterial 
filtrate was employed each time in order to avoid acquirement of specific active 
immunity (3).  They were B. typhosus,  meningococcus Group III (44B strain), 
meningococcus Group I  (44 D strain) and B.  coli "agar washings" filtrates, re- 
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spectively.  These  experiments are summarized in Table I.  In this  table and 
others of this paper, the expression positive rabbit means that there was obtained 
in the rabbit's prepared skin site a severe hemorrhagic and necrotic lesion 4 to 5 
hours after the test intravenous injection.  The  lesions which were intense in 
the majority of  rabbits  were characteristic of  the  phenomenon of  local skin 
reactivity to bacterial filtrates (4).  By negative rabbit is meant absence of skin 
reaction following  the test intravenous injection. 
As is seen from Table I, rabbits actively sensitized to animal pro- 
teins (i.e.,  blood sera and egg albumin) responded with formation of 
reacting factors in vivo upon intravenous reinjection of the same protein 
after an adequate incubation period? 
The  factors  were  apparently  formed  immediately after  the  test 
intravenous injection, inasmuch as the reactions in the prepared  skin 
sites had developed to their fullest extent 4 to 5 hours later. 
The state of active sensitization could be demonstrated in the man- 
ner described 7 to 8  days after a  single intravenous injection and it 
persisted for longer periods of time (i.e.,  12 days).  Shorter incubation 
periods were inadequate (i.e.,  2  days).  The state could be also at- 
tained with diluted sera.  A single injection of 1 cc. horse serum diluted 
1:10  induced sensitization after 8  days.  Higher dilutions of horse 
serum also  elicited it  but  only upon  repeated  sensitizing injections 
and after longer incubation periods  (i.e.,  dilution 1:100,  14  days2). 
The human serum appeared to be of high antigenicity for rabbits be- 
cause even 1 cc. of dilution 1 : 10,000 injected twice produced sensitiza- 
tion 8 days after the second sensitizing injection.  The antigen for test 
injections could also  be  used in  comparatively small amounts (i.e., 
1 cc. horse serum diluted 1:100). 
The experiments of Table I also demonstrated the specificity of the 
sensitization  described.  Rabbits  sensitized  to  small  amounts  of 
horse serum, while showing reactions with the same serum,  gave no 
reactions upon retests with human, guinea pig, rabbit, sheep and goat 
sera.  Similarly, rabbits sensitized to human serum showed reactions 
1  The term sensitization  employed  in this paper is limited to the type described. 
2  The term incubation period in the text  and tables refers to the interval of 
time between the last  sensitizing and  the first test injection.  When  repeated 
sensitizing injections were made the true incubation period which was necessary, 
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with human serum but failed to respond to horse serum; and  those 
sensitized to egg albumin did not react with horse serum.  However, 
the specificity displayed by serum proteins of various animal species 
did not hold when repeated sensitization with large doses was extended 
over prolonged periods of time.  Thus, rabbits sensitized by four in- 
travenous injections of undiluted horse serum in doses of 1 to 4 cc., 
per kilo of body weight, reacted with sheep serum after an incubation 
period of 22  days, although failing to  respond to  guinea pig serum. 
Sera of these rabbits obtained before the test injections were titrated 
for precipitins against sheep and guinea pig sera.  They gave precipi- 
tation with sheep serum diluted 1 : 20 and no precipitation with guinea 
pig  serum.  It  was  shown,  therefore, that  the  cross-reactions  with 
heterologous sera were coincidental with cross-precipitations.  In a re- 
cent  paper,  Hektoen  and  Cole offered an explanation for cross-pre- 
cipitation  obtained  after  employment of  large doses of antigen  (5). 
Formation of Reacting Factors in Passively Sensitized Rabbits 
The purpose of the work now to  be taken up  was  to  determine 
whether reacting factors would form in vivo in passively sensitized rab- 
bits.  Rabbits were prepared by a  single intradermal injection of B. 
typhosus  (TL)  "agar washings"  filtrate and  23½  and 24  hours  later 
injected intravenously, first, with the antigen, and secondly, with the 
antibody, respectively.  In some experiments the order of intravenous 
injections was  reversed; in  others the interval of time was  varied. 
Parallel experiments were done in which mixtures of the antigen with 
the antibody made in vitro were injected intravenously into prepared 
rabbits.  The results are summarized in Table II. 
As seen from Table II, two separate intravenous injections of pre- 
cipitinogen-containing  serum  (i.e.,  normal human  serum)  and  pre- 
cipitating  antiserum  (i.e.,  anti-human  horse  serum)  elicited  severe 
hemorrhagic necrosis in  skin  sites  prepared  with  bacterial  filtrates. 
No reactions were obtained when each of the sera was injected alone 
in  the same dose; when either the  anti-human horse serum  or  the 
normal human serum was reinjected twice, or when there were made 
two separate injections of normal horse and normal human sera.  The 
experiments demonstrated, therefore, formation of reacting factors in 
vivo through the interaction of passively acquired antigen and antibody. TABLE  II 
Formation  of Reacting  Factors  in  Passively  Sensitized  Rabbits 
Intravenous injections  Interval between 
skin and intravenous 
1st  2nd  injections 
2 cc. horse Serum 416 
1  "  human  "  I 
1  "  horse  "  416 
1  "  human  "  I 
1  "  "  "  SL 
1  "  "  "  918 
1  "  "  "  B 
1  "  "  "  Sc 
1  "  "  "  416 
1  "  "  "  416 
1  "  anti-human  horse 
Serum 7/405 
Mixture of  l  part human 
serum--1 part anti-hu- 
man horse Serum 7/405 
1 cc. human Serum I 
1  "  "  "  I  di- 
luted 1 : 10 
1 cc. human Serum I 
1  "  "  "  I 
1  "  "  "  I 
1  "  "  "  I 
1  "  "  "  I 
1  "  "  "  I 
1  "  "  "  I 
Human serum 2 cc. Group 
III 
Pneumococcus Type  III 
culture filtrate 3 cc. 
1  cc.  Antipneumococcus 
Type III horse serum 
3 cc. Pneumococcus Type 
III culture filtrate 
1 cc. human Serum I 
1 cc. horse Serum 416 
1  "  human  "  I 
1  "  horse  "  416 
1  "  "  "  416 
1  "  "  "  416 
1  "  "  "  416 
1  "  human  "  XIII 
1  "  "  "  XIV 
i  "  "  "  I 
i  cc.  anti-human  horse 
Serum 7/405 
1  cc.  anti-human  horse 
Serum 7/486 
1  cc.  anti-human horse 
Serum 7/501 
1  cc.  anti-human horse 
Serum 7/515 
1  cc.  anti-human horse 
Serum 7/522 
1  cc.  anti-human  horse 
Serum 7/527 
1  cc.  anti-human horse 
Serum 7/540 
1  cc.  anti-human horse 
Serum 7/486 
1 cc. 5% human red blood 
cells Group II 
1  cc.  Antipneumococcus 
Type III horse serum 
1  cc.  anti-human  horse 
Serum 7/486 
]$v$. 
24 
24 
23½ 
23½ 
23½ 
23½ 
23½ 
23½ 
23½ 
23½ 
23½ 
24 
23½ 
23½ 
23½ 
23½ 
23½ 
23½ 
23½ 
23½ 
rai~. 
15 
]$r$. 
23½ 
24 
24 
23½ 
24 hrs. prior to 
skin injection 
Interval 
between 
1st and 2nd 
intravenous 
injections 
hrs. 
-g 
½ 
23[ 
½ 
½ 
24 
Re- 
sults 
0/3 
0/3 
0/6 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
3/0 
3/0 
3/0 
3/0 
0/3 
0/3 
2/1 
0/3 
0/3 
0/3 
1/2 
2/6 
0/4 
0/3 
5/1 
0/3 
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Positive rabbits were obtained when the interval  of time between 
the injections of serum precipitinogen and precipitating antiserum was 
½ hour,  and  also,  in one experiment,  when  it  was 23~  hours.  A  48 
hour interval gave negative results. 
In the majority of experiments of Table II antigen was injected first 
and the antibody second.  No reactions were elicited when the order of 
intravenous injections was reversed.  Precipitation titrations with the 
serum precipitinogen  and  precipitating  antiserum  showed that  there 
were required larger amounts of antibody than antigen for the precipita- 
tion.  Thus, human serum diluted 1:1,000 precipitated with undiluted 
TABLE  III 
Precipitation  Titer of Anti-Human Horse Sera 
Undiluted precipi- 
tating antisera 
Human sera 
Precipitino- 
gen sera 
7/405 
7/486 
7/5Ol 
7/515 
7/522 
7/527 
7/540 
Precipitation results  with various dilutions  of 
precipitinogen 
1:2  1:10 
3+  3+ 
4+  4+ 
4+  4+ 
2+  2+ 
4+  4+ 
4+  4+ 
4+  4+ 
4+ 
2+ 
4+ 
2+ 
1+ 
1+ 
2+ 
__1:100 ~ 
4- 
Formation 
of reacting 
factors in 
vivo 
=  serum induced formation of reacting factors in vivo. 
0  = serum did not induce formation of reacting factors in vivo. 
anti-human horse serum, whilst the antibody diluted 1 : 40 already failed 
to precipitate with undiluted  and diluted  1:10 human  serum.  Inas- 
much as unquestionably a part of the injected serum rapidly disappears 
from the blood stream, it is conceivable that in the latter experiment 
the  reactions  did  not  take  place  because  an  insufficient  amount  of 
antibody remained in the blood stream at the time of the subsequent 
injection of the antigen. 
As is also seen from Table II, there were tested various bleedings of 
Horse 7.  Since every bleeding did not give positive results it seemed 
of interest to determine their precipitation titers (Table III). 
As is seen from a comparison of the respective results of Tables II and GREGORY  SHWARTZM.AN  695 
III,  no  relationship  could  be  established  between  the  precipitin 
contents and the ability of the sera to induce formation of reacting 
factors upon combination with the precipitinogen in vivo. 
The results of Table II demonstrate in addition that the interaction 
of inactive Pneumococcus Type III culture filtrates with Antipneumo- 
coccus Type III horse serum induced formation of reacting factors in 
vivo.  This observation is corroborated by previously reported results 
on the reacting potency of mixtures of the same filtrates and sera made 
in vitro (6). 
There was obtained suggestive evidence that the factors could also 
be formed through the interaction of hemagglutinins with human red 
blood  cells.  The  results  are  not  sufficiently conclusive to  warrant 
special consideration in this paper.  Further work is in progress. 
No clear-cut results could be obtained as yet concerning formation 
of reacting factors in vivo through the interaction either of homologous 
(i.e. rabbit)  antiserum with heterologous serum or heterologous anti- 
serum with homologous (i.e. rabbit)  serum.  Further experiments are 
also under way. 
E~ect of Reacting Factors Formed in Vivo upon Skin Sites Prepared by 
Non-Bacterial  Substances 
In order to emphasize the essential r61e of bacterial filtrates in the 
phenomenon under discussion the experiments embodied in Table IV 
were done. 
As seen from Table  IV,  no  reactions were obtained when rabbits 
were injected intradermally, either with the serum precipitinogen or 
the precipitating antiserum, and after various intervals of time rein- 
jected intravenously with the precipitating antiserum in the case of 
the former, and with the serum precipitinogen in the case of the lat- 
ter.  Moreover, whilst mixtures of serum precipitinogen with precipi- 
tating  antiserum injected intravenously elicited severe hemorrhagic 
necrosis in  skin sites prepared with a  potent bacterial filtrate,  they 
had no  effect upon sites prepared either with the precipitinogen or 
the precipitins.  Also,  an intravenous injection of horse serum into 
rabbits  actively  sensitized  to  the  serum produced  no  effect either 
upon areas in which there was induced inflammation with turpentine, 
or in areas prepared with horse serum.  As is seen from experiments 696  LOCAL SKIN  REACTIVITY 
TABLE  IV 
Effect of Reacting Factors Formed in  Vivo upon Sites Prepared with Non-Bacterial 
Substances 
Preliminary  treatment 
None 
[¢ 
£g 
Skin-preparatory  injection* 
Human serum 
Anti-human  horse 
Serum 7/405 
B.  typlwsus  culture 
filtrate 
Anti-human  horse 
Test intravenous  injection 
per kilo  of body  weight 
1  cc.  anti-human 
horse Serum 4/405 
¢c  cc 
2 cc. of mixture of 1 
part  of  4/405--1 
part human serum 
diluted 1:4 
1 CC. human serum 
Interval 
between 
skin and 
intravenous 
injection 
]~r$. 
1 
4 
6 
24 
24 
24 
24 
24 
1 cc. horse serum in- 
travenously  1  wk. 
prior to skin injec- 
tion 
Serum7/405 
B.  typhosus  culture 
filtrate 
Turpentine  diluted 
1:5 
Horse serum 
1  "  horse  " 
25 B. typlwsus react- 
ing units 
24 
24 
24 
24 
Resultst 
0/3 
0/3 
0/3 
0/3 
0/3 
0/3 
3/0 
0/3 
3/0 
~0/4 
0/6 
0/3 
* 0.25 cc. of undiluted material was used for each intradermal injection. 
t The numerator indicates the number of positive rabbits, the denominator the 
number of  negative rabbits.  The  sum indicates the  total  number of  rabbits 
tested. 
:~ Abscesses, no hemorrhagic necrosis. 
of Tables I  and IV, an intravenous injection of horse serum into sensi- 
tized rabbits invariably produced severe lesions at the sites prepared 
with a  bacterial filtrate. 
Thus,  the  experiments  clearly  showed  that  the  antigen-antibody 
interaction elicited in the manner described, while producing no effect GREGORY  SHWARTZMAN  697 
upon  normal,  sensitized  and  inflamed  tissues,  was  responsible  for 
severe injury to tissues prepared with bacterial filtrates. 
Effect  of Intradermal  Reinjection  of Antigen-Antibody  Mixture  upon 
Sites Prepared  with Bacterial Filtrates 
There  remained the question whether the antigen-antibody inter- 
action taking place outside the blood stream would also bring about a 
similar injurious effect upon skin sites prepared with bacterial filtrates. 
The following experiments were done. 
Six rabbits each received a single intradermal injection of 0.25 cc. of undiluted 
B. typhosus (TL) "agar washings" filtrate.  24 hours later the same areas were 
each reinjected with 0.5 cc. of a mixture consisting  of one part of anti-human horse 
Serum 7/527 and one part oi human serum diluted 1:4.  The same mixture was 
also injected intravenously into three  rabbits prepared by a single intradermal 
injection of the above B. typhosus filtrate 24 hours before.  The rabbits reinjected 
intradermally showed no hemorrhagic necrosis during the following  48 hours of 
observation.  The rabbits reinjected intravenously had severe hemorrhagic and 
necrotic lesions at the prepared skin sites 4 to 5 hours later. 
These experiments demonstrate that the sine qua non of the phenom- 
enon is that the antigen-antibody  mixture be brought into contact with 
the prepared skin areas via the blood stream. 
reSCiSSION AND  CONCLUSIONS 
The data presented in this paper offer a new method for the demon- 
stration of antigen-antibody interaction.  It is easily carried out, as 
follows: 
A  rabbit sensitized to some animal protein receives an intradermal 
injection of 0.25 cc. of undiluted bacterial filtrate of ascertained skin- 
preparatory potency.  24 hours after the skin preparation the rabbit 
is injected intravenously with the same animal protein.  From 4  to 
5  hours later there appears  severe hemorrhagic necrosis at the pre- 
pared skin site. 
Inasmuch as  the necessary state of sensitization can be obtained 
by a single intravenous injection of a protein and a 1 week incubation 
period is  sufficient, the method offers the  advantages of speed  and 
simplicity.  The readings are reliable and clear-cut since the incidence 
of positive rabbits is high (i.e.  with some proteins about 85 per cent 698  LOCAL  SKIN  REACTIVITY 
of animals tested after a  single sensitizing injection) and the severe 
hemorrhagic necrosis makes the reaction unmistakable.  The test is 
highly sensitive and strictly specific, unless there are made repeated 
sensitizing  injections  of  large  doses  of  the  antigen.  Anaphylactic 
shock in  rabbits  is  difficult to  elicit,  and  the test  injections of the 
proteins do not have lethal effect upon these animals. 
It is also possible to elicit severe reaction in the prepared skin site of 
non-sensitized rabbits upon separate intravenous injections of antigen 
and antibody (i.e., passive transfer). 
The test described is clearly differentiated from the Arthus phenome- 
non by the following important features. 
(1)  A  single  sensitizing  injection  is  sufficient.  (2)  The  reaction 
can be obtained in rabbits which are not ready as yet for the Arthus 
phenomenon.  (3)  Skin preparation with a bacterial filtrate of ascer- 
tained  skin-preparatory  potency  is  essential.  (4)  The  reaction  is 
limited to the prepared skin  site.  (5)  The antigen-antibody interac- 
tion has to take place in the blood stream. 
It  has  been  previously  shown  (1)  that  similar  reactions  can be 
obtained in prepared rabbits by an intravenous injection of antigen- 
antibody mixture made in vitro.  Considerable evidence has been ac- 
cumulated to  prove  that  the injury was not due to  the mechanical 
effect of the precipitate in the blood  stream but to a  toxic principle 
formed through the antigen-antibody interaction.  In this paper there 
is presented additional proof of the fact, inasmuch as the precipitation 
titer bears no  relation to  the resulting toxic effect of separately in- 
jected serum precipitinogens and precipitating antisera. 
The part of the phenomenon under consideration in this paper deals 
with toxic factors formed in vivo through antigen-antibody interaction. 
These  factors  are  capable  of inducing via  the  blood  stream  severe 
injury  in  tissues  prepared  by  potent  bacterial  filtrates.  As  was 
pointed out in previous papers (7) and also shown again in this paper, 
the preparatory injection of a bacterial filtrate brings about a transient 
state  of  vulnerability  in  the  animal  cell.  3  Vulnerability  may  or 
may not be associated with active inflammation.  A  great  number 
of observations have afforded unquestionable proof that the primary 
The generalization to the animal cell is justified because the state of vulnera- 
bility was demonstrated in animals of various species and in various organs and 
tissues (11). GREGORY  SHWARTZMAN  699 
injection may induce vulnerability in  spite  of complete absence of 
primary erythema and may fail to elicit it in the face of active inflam- 
mation produced either by  certain inactive bacterial filtrates or by 
non-bacterial  inflammatory substances  (i.e.  broth,  turpentine, gum 
tragacanth, egg albumin, horse serum, blood plasma, India ink, agar, 
gelatine, sodium arsenate, heparin, histamine, spirits of nitroglycerine, 
eserine hydrochloride, trypan blue, adrenaline, pituitrin, silicic acid, 
charcoal,  infusorial earth,  paraffin oil and caseine).  Recently Opie 
(8),  Menkin (9)  and Cannon and Pacheco  (10)  emphasized fixation 
of colloidal particles  in  the  blood  stream  by  inflamed  tissues.  If 
one should grant that some sort of undetectable inflammation is in- 
variably  elicited by  skin injection of a  bacterial filtrate,  then it  is 
easily understood why the reacting factors formed or introduced into 
the blood stream localize in the prepared area.  However, this alone 
does not explain why a severe reaction takes place only in areas pre- 
pared with bacterial filtrates of ascertained skin-preparatory potency 
and  fails  to  occur  in  other  inflamed  areas.  For  these reasons,  it 
must be concluded beyond any doubt that the bacterial filtrates de- 
scribed (i.e. those of high skin-preparatory potency) possess in addition 
the  ability of inducing a  certain state  of vulnerability.  Thus,  the 
vulnerable  cell becomes  a  reagent  for  the  detection of  apparently 
widely separated groups of toxic principles, all with one characteristic 
feature in common; i.e., the production of injury via the blood stream. 
These principles are as follows: 
1.  Neutralizable  and  Antigenic  Exotoxic  Substances.--In  previous 
communications it has been demonstrated that bacterial substances 
identical or closely related to true exotoxins are capable of eliciting 
severe injury in  the vulnerable cell.  The  observations lead  to the 
demonstration  of  a  new  category  of  antigenic  and  neutralizable 
exotoxins with a distinct difference between them and true exotoxins 
in the mechanism of the effect.  The classical toxins are capable  of 
primary local injury, whilst those under discussion inflict injury via 
the  blood  stream  on  vulnerable  tissues.  It  has  been  previously 
assumed  (13)  that  these toxins act  as  agents which produce a  dis- 
turbance in the colloidal state of the blood.  As a result, certain toxic 
factors are formed in vivo which attack the vulnerable cell. 
2.  Formation of Reacting  Factors Resulting from  Intravenous  Injec- 
tion of Agar.--It has been shown by Sickles (12) and corroborated by 700  LOCAL  SKIN  REACTMTY 
the present author (1) that afar, whilst possessing no skin-preparatory 
potency,  when  injected  intravenously  is  capable  of  eliciting  the 
reaction in areas prepared with potent bacterial filtrates.  Inasmuch 
as the afar produces the reaction only via the blood stream, it may be 
concluded that it also acts as an agent producing a disturbance in the 
colloidal  state of the blood,  necessary for the formation of reacting 
factors injurious to the vulnerable cell.  It has been demonstrated by 
Bordet (13) that addition of afar to blood serum induces formation of 
anaphylatoxins.  It has been further observed by Novy and De Kruif 
(14)  that afar also  forms anaphylatoxins in vivo.  Thus, correlative 
studies  on  anaphylatoxins  and  the  phenomenon  under  discussion 
suggest themselves. 
3.  Formation  of Reacting  Factors Resulting from in  Vivo Interaction 
of Non-Bacterial  Antigens with Antibodies.--As described in this paper, 
the antigen-antibody combination in vivo brings about formation of 
toxic factors which are detected by the vulnerable cell.  It also  re- 
mains to determine whether the toxic principles formed by the antigen- 
antibody combination of anaphylaxis and  Arthus phenomenon are 
similar to  the reacting factors of the phenomenon under discussion. 
It  is  conceivable that  identical toxic factors may produce different 
effects in various tissues,  the vulnerable cell of this phenomenon re- 
sponding with hemorrhagic necrosis. 
4.  Formation  of Reacting  Factors Resulting from in  Vivo Interaction 
of Bacterial Antigens with Antibodies.--It has been previously reported 
that  mixtures  of  inactive  pneumococcus filtrates  with  homologous 
antisera  are  capable of eliciting severe reactions in  skin  sites  with 
induced vulnerability.  In this paper it has been shown that separate 
(½ hour apart) intravenous injections of the inactive filtrate and the 
serum lead to formation of reacting factors in vivo with the resulting 
severe injury to  the vulnerable skin  area.  These observations are 
interesting from the point of view of immunopathology.  The state 
of vulnerability can be induced not only by bacterial filtrates but by 
active infections as  well  (15).  For  this  reason it  is  admissible  to 
assume that the reacting factors formed through the interaction of the 
antigen secreted by the diseased focus and the actively acquired anti- 
bodies may produce, v/a the blood stream, severe injury in vulnerable 
tissues and organs.  This mechanism of production of injury offers GREGORY  SHWARTZMAN  701 
a new working hypothesis for problems concerning relapse of infections, 
complications, metastatic lesions and generalized spread of disease. 
There is also suggested the possibility that focal reactions of tuberculin 
hypersensitiveness may  be  based  on  this  mechanism.  Tuberculin 
combined with tuberculous antibodies in vivo  may bring about the 
formation of  reacting  factors.  These factors  would induce  severe 
injury in tuberculous loci, inasmuch as the latter were shown to possess 
the state of vulnerability necessary for the phenomenon (16). 
Border  observed  that  reacting  factors  of  heterologous  bacterial 
filtrates were capable of reproducing the phenomenon  under discussion 
at the site of a tuberculous lesion.  He called this non-specific allergy. 
In view of the observations reported here one arrives at an explanation 
of  specific  and  non-specific  allergic  manifestations  in  tuberculous 
lesions in which both may be an expression of the same mechanism. 
Thus, in terms of the phenomenon, active infections elicit a  state of 
vulnerability in the diseased tissue.  Severe injury then can be in- 
duced in this tissue by means of potent heterologous bacterial filtrates, 
since it has been shown (7) that  preparatory and reacting  factors of 
unrelated bacterial species can substitute for each other, provided they 
are potent (i.e., non-specific allergy).  Also injury can be produced in 
infected tissues by reacting factors formed through the interaction of 
the  injected specific antigen with  the  actively  acquired  antibodies 
of  the  infected  animals  (i.e.,  specific  allergy  or  bacterial  hyper- 
sensitiveness). 
Inasmuch as the interaction of animal protein with the homologous 
antibody forms reacting factors injurious to tissues made vulnerable 
by bacterial filtrates or infections, there remains the question of the 
influence of serum sickness upon the course of infectious diseases. 
To  recapitulate,  the  essential  mechanism of the  phenomenon of 
local skin reactivity to bacterial filtrates consists in the alteration of 
tissues by bacterial filtrates or infections  whereby they become vulnera- 
ble to a  variety of toxic principles which act via the blood stream. 
These toxic principles are as follows: 
Neutralizable  and  antigenic  exotoxic  substances  (true  toxins?); 
toxic  factors  formed through  a  colloidal  disturbance  in  the  blood 
stream  (anaphylatoxins?);  toxic  factors  resulting  from  the  in  vivo 
interaction of non-bacterial antigens with homologous antibodies (true 702  LOCAL  SKIN  REACTMTY 
anaphylaxis?) and toxic factors resulting from the in vivo interaction 
of  bacterial  antigens  with  specific  antibodies  (bacterial  hypersensi- 
tiveness?). 
Thus the phenomenon of local skin reactivity to bacterial filtrates 
must be considered in various fields of immunology.  It offers interest- 
ing possibilities for correlative studies. 
SUMMARY 
In this  paper there is  described a ncw mcthod for  the  demonstration 
of antigen-antibody combination, as follows: 
A rabbit  sensitized  a  week  previously  to  some animal  protein  receives 
a skin-preparatory injection  of a potent bactcrial  filtrate.  24 hours 
after  the  skin  preparation the  rabbit  is  injcctcd  intravenously with the 
same animal protein.  From 4 to 5 hours later  there appears severe 
hemorrhagic necrosis  at the prepared skin site. 
The incidence of  positive  results  is  high.  A single  sensitizing  injec- 
tion and 1 week incubation period arc sufficient. The tcst  is  highly 
specific  unless  repeated sensitizing  injections  of  large  doses of antigen 
are made.  The ncccssary scnsitization  can bc clicitcd  with minute 
quantities  of animal proteins. 
It is also  possible to elicit  severe reactions in the prepared skin 
sitcs of non-sensitized rabbits  upon separate intravenous injections 
of non-bacterial and bactcrial antigens and homologous antibodics 
(i.e.,  passive transfer). 
Thc relation  of the phcnomenon of  local  skin reactivity  to bactcrial 
filtrates  to various fields  of  immunology is  discussed  in  the  light  of  the 
above observations. 
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